nonsteroidal antiandrogen nsaa quinoline group developed ligand pharmaceuticals along selective androgen receptor modulators sarms like never drug highaffinity antagonist androgen receptor ar ki value nm found inhibit growth ventral prostate seminal vesicles male rats without increasing circulating levels luteinizing hormone however tissue selectivity assessed orally active shows greater oral potency arylpropionamide nsaa derivative also potent nsaa appears possess greater potency conversely analogue sarm potent androgenic activity equivalent dihydrotestosterone drug article relating genitourinary system stub help wikipedia expanding